| Name | Title | Contact Details |
|---|
Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner. Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health. We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities.
WellAWARE Systems, in partnership with Volunteers of America (VOA) and The Evangelical Lutheran Good Samaritan Society (GSS), offers the opportunity for enhanced quality of life for our aging population through an innovative approach to wellness and safety for senior living.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Health Industry Distributors Association is a Alexandria, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lincoln Health is a healthcare organization affiliated with the Huntsville Hospital Health System.